Getinge รายงานผลการดำเนินงานช่วง 7-9 เดือน 2569: ความน่าเชื่อถือที่เพิ่มขึ้น, การไหลเวียนเงินที่แข็งแกร่ง และความพึงพอใจของลูกค้าที่สูงขึ้น

Getinge published its interim financial results for the third quarter of 2026, highlighting robust performance across multiple key operational metrics. The medical technology firm successfully delivered positive organic growth in both order intake and net sales during the period. Furthermore, strategic cost management initiatives allowed the company to expand its profitability margins and generate solid free cash flow. Customer satisfaction scores also trended higher, reflecting successful execution in healthcare product delivery and service quality. Leadership expressed satisfaction with the resilience of the business despite lingering macroeconomic pressures in global healthcare markets. Investors responded favorably to the balanced combination of top-line expansion and disciplined financial stewardship.